Cue Biopharma presents 'positive' update from Phase 1 trials of CUE-101, CUE-102

Retrieved on: 2024-11-08 22:24:13

Tags for this article:

Click the tags to see associated articles and topics

Cue Biopharma presents 'positive' update from Phase 1 trials of CUE-101, CUE-102. View article details on hiswai:

Excerpt

Cue Biopharma (CUE) presented updated data from its Phase 1 dose escalation and expansion trial evaluating its lead oncology asset from the Immu.

Article found on: markets.businessinsider.com